Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

Market Cap	3.54B +30.1%
Revenue (ttm)	510.33M +17.5%
Net Income	123.82M +3.4%
EPS	0.82 +2.2%
Shares Out	150.34M
PE Ratio	28.85
Forward PE	n/a
Dividend	0.11 (0.48%)
Ex-Dividend Date	May 20, 2025

Volume	1,059,512
Average Volume	1,368,378
Open	23.74
Previous Close	23.83
Day's Range	23.44 - 23.92
52-Week Range	15.70 - 27.95
Beta	0.83
RSI	49.22
Earnings Date	Mar 27, 2026

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, sale, and import and export of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, cardiovascular, antispasmodic, antibacterial agent, histamines drug, and anticonvulsant. It also provides chemical products for intermediates and food additives. Zhej...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1998
• Employees: 663
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 001367

Financial Performance

In 2024, SHE:001367's revenue was 471.51 million, an increase of 18.63% compared to the previous year's 397.45 million. Earnings were 122.56 million, an increase of 17.09%.